Want to join the conversation?
American pharmaceutical company $MRK posted lower 4Q15 results hurt by acquisition and divestiture-related costs. $MRK said, net income fell 86% to $976MM or $0.35 per share, compared with earnings of $7,316MM, or $2.54 per share a year ago. Revenue fell 2.5% to $10.21Bil. Excluding items, $MRK earned $0.93 per share.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.